Immunitybio and ncartes enter collaboration agreement on clinical trial data fulfillment

Fremont, calif. , nov. 21, 2024 /prnewswire/ -- immunitybio, inc. (nasdaq: ibrx), a vertically integrated biotechnology company, and ncartes, inc., a transformational cloud software platform provider, announced a collaboration agreement aimed at automating and streamlining the data fulfillment process for clinical trials.
IBRX Ratings Summary
IBRX Quant Ranking